RXRA c.938T>C ;(p.F313S)

Variant ID: 9-137320981-T-C

NM_002957.4(RXRA):c.938T>C;(p.F313S)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Spatially interacting phosphorylation sites and mutations in cancer.

Nature Communications
Huang, Kuan-Lin KL; Scott, Adam D AD; Zhou, Daniel Cui DC; Wang, Liang-Bo LB; Weerasinghe, Amila A; Elmas, Abdulkadir A; Liu, Ruiyang R; Wu, Yige Y; Wendl, Michael C MC; Wyczalkowski, Matthew A MA; Baral, Jessika J; Sengupta, Sohini S; Lai, Chin-Wen CW; Ruggles, Kelly K; Payne, Samuel H SH; Raphael, Benjamin B; Fenyƶ, David D; Chen, Ken K; Mills, Gordon G; Ding, Li L
Publication Date: 2021-04-19

Variant appearance in text: RXRA: F313S
PubMed Link: 33875650
Variant Present in the following documents:
  • 41467_2021_22481_MOESM4_ESM.xlsx, sheet 1
  • 41467_2021_22481_MOESM4_ESM.xlsx, sheet 6
View BVdb publication page



NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling.

Cancer Cell
Zhou, Hu H; Liu, Wen W; Su, Ying Y; Wei, Zhen Z; Liu, Jie J; Kolluri, Siva Kumar SK; Wu, Hua H; Cao, Yu Y; Chen, Jiebo J; Wu, Yin Y; Yan, Tingdong T; Cao, Xihua X; Gao, Weiwei W; Molotkov, Andrei A; Jiang, Fuquan F; Li, Wen-Gang WG; Lin, Bingzhen B; Zhang, Hai-Ping HP; Yu, Jinghua J; Luo, Shi-Peng SP; Zeng, Jin-Zhang JZ; Duester, Gregg G; Huang, Pei-Qiang PQ; Zhang, Xiao-Kun XK
Publication Date: 2010-06-15

Variant appearance in text: RXRalpha: F313S
PubMed Link: 20541701
Variant Present in the following documents:
  • Main text
View BVdb publication page